• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[高血压与肾脏]

[Hypertension and the kidney].

作者信息

Hohenstein Katharina, Watschinger Bruno

机构信息

Klinische Abteilung für Nephrologie und Dialyse, Universitätsklinik für Innere Medizin III, Medizinische Universität Wien, Wien, Austria.

出版信息

Wien Med Wochenschr. 2008;158(13-14):359-64. doi: 10.1007/s10354-008-0558-3.

DOI:10.1007/s10354-008-0558-3
PMID:18677585
Abstract

Hypertension and proteinuria are common risk factors for cardiovascular morbidity and mortality, as well as for the progression of renal disease. Renal functional impairment represents an independent cardiovascular risk factor by itself. Strict antihypertensive therapy and measures to maximally reduce proteinuria can substantially improve the prognosis of renal patients. This review summarizes current evidence for the role of hypertension and proteinuria with regard to renal and cardiovascular outcomes and for the importance of intensive antihypertensive and anti-proteinuric measures.

摘要

高血压和蛋白尿是心血管疾病发病和死亡以及肾脏疾病进展的常见危险因素。肾功能损害本身就是一个独立的心血管危险因素。严格的抗高血压治疗以及最大程度降低蛋白尿的措施可显著改善肾病患者的预后。本综述总结了关于高血压和蛋白尿在肾脏及心血管结局方面的作用以及强化抗高血压和抗蛋白尿措施重要性的现有证据。

相似文献

1
[Hypertension and the kidney].[高血压与肾脏]
Wien Med Wochenschr. 2008;158(13-14):359-64. doi: 10.1007/s10354-008-0558-3.
2
[Editorial: hypertensiology].[社论:高血压学]
Wien Med Wochenschr. 2008;158(13-14):357-8. doi: 10.1007/s10354-008-0557-4.
3
Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.高血压患者的亚临床肾损伤:打开一扇观察心血管系统的肾脏之窗。聚焦微量白蛋白尿。
Adv Exp Med Biol. 2017;956:279-306. doi: 10.1007/5584_2016_85.
4
[Renal effects of combined anti-hypertensive treatments].[联合抗高血压治疗的肾脏效应]
Recenti Prog Med. 2010 Feb;101(2):70-7.
5
A review of renal, cardiovascular and mortality endpoints in antihypertensive trials in diabetic patients.糖尿病患者抗高血压试验中肾脏、心血管及死亡率终点的综述。
Blood Press. 2011 Dec;20(6):322-34. doi: 10.3109/08037051.2011.602878. Epub 2011 Sep 22.
6
Blood pressure control, proteinuria, and the progression of renal disease. The Modification of Diet in Renal Disease Study.血压控制、蛋白尿与肾脏疾病进展。肾脏疾病饮食调整研究。
Ann Intern Med. 1995 Nov 15;123(10):754-62. doi: 10.7326/0003-4819-123-10-199511150-00003.
7
Cardiovascular risk in patients with mild renal insufficiency: implications for the use of ACE inhibitors.轻度肾功能不全患者的心血管风险:对使用血管紧张素转换酶抑制剂的启示
Presse Med. 2005 Oct 22;34(18):1303-8. doi: 10.1016/s0755-4982(05)84178-8.
8
The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study.较低目标血压对肾脏疾病进展的影响:肾脏病饮食改良研究的长期随访
Ann Intern Med. 2005 Mar 1;142(5):342-51. doi: 10.7326/0003-4819-142-5-200503010-00009.
9
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).雷米普利对蛋白尿性非糖尿病肾病患者肾小球滤过率下降及终末期肾衰竭风险影响的随机安慰剂对照试验。意大利肾脏病流行病学研究组(GISEN组)
Lancet. 1997 Jun 28;349(9069):1857-63.
10
Efonidipine improves renal function and decreases proteinuria in elderly hypertensive patients in the JATOS study.在JATOS研究中,依福地平可改善老年高血压患者的肾功能并减少蛋白尿。
Hypertens Res. 2010 Nov;33(11):1112-3. doi: 10.1038/hr.2010.150. Epub 2010 Sep 2.

引用本文的文献

1
Efficacy of Huangqi Injection in the Treatment of Hypertensive Nephropathy: A Systematic Review and Meta-Analysis.黄芪注射液治疗高血压肾病的疗效:系统评价与Meta分析
Front Med (Lausanne). 2022 Apr 25;9:838256. doi: 10.3389/fmed.2022.838256. eCollection 2022.

本文引用的文献

1
Reducing cardiovascular events in high-risk patients: the challenge of managing hypertension in patients with diabetic renal disease.降低高危患者的心血管事件:糖尿病肾病患者高血压管理的挑战
J Clin Hypertens (Greenwich). 2007 Nov;9(11 Suppl 4):16-25. doi: 10.1111/j.1524-6175.2007.07723.x.
2
Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.肾脏疾病的进展:肾素-血管紧张素系统阻断的肾脏保护特异性
Clin J Am Soc Nephrol. 2006 Sep;1(5):1054-65. doi: 10.2215/CJN.02231205. Epub 2006 Jul 12.
3
Chronic kidney disease: effects on the cardiovascular system.
慢性肾脏病:对心血管系统的影响
Circulation. 2007 Jul 3;116(1):85-97. doi: 10.1161/CIRCULATIONAHA.106.678342.
4
Proteinuria as a therapeutic target in patients with chronic kidney disease.蛋白尿作为慢性肾脏病患者的治疗靶点。
Am J Nephrol. 2007;27(3):287-93. doi: 10.1159/000101958. Epub 2007 Apr 23.
5
Antihypertensive therapy in the presence of proteinuria.存在蛋白尿时的抗高血压治疗。
Am J Kidney Dis. 2007 Jan;49(1):12-26. doi: 10.1053/j.ajkd.2006.10.014.
6
Combination therapy with an angiotensin receptor blocker and an ACE inhibitor in proteinuric renal disease: a systematic review of the efficacy and safety data.血管紧张素受体阻滞剂与ACE抑制剂联合治疗蛋白尿性肾病:疗效和安全性数据的系统评价
Am J Kidney Dis. 2006 Jul;48(1):8-20. doi: 10.1053/j.ajkd.2006.04.077.
7
Importance of blood pressure control in chronic kidney disease.慢性肾脏病中血压控制的重要性。
J Am Soc Nephrol. 2006 Apr;17(4 Suppl 2):S98-103. doi: 10.1681/ASN.2005121319.
8
Heart and kidney: fatal twins?心脏与肾脏:致命组合?
Am J Med. 2006 May;119(5 Suppl 1):S31-9. doi: 10.1016/j.amjmed.2006.01.012.
9
Hypertension in renal parenchymal disease: why is it so resistant to treatment?肾实质性疾病中的高血压:为何对治疗如此难治?
Kidney Int. 2006 Mar;69(6):967-73. doi: 10.1038/sj.ki.5000177.
10
Primary hypertension and nephropathy.原发性高血压与肾病。
Curr Opin Nephrol Hypertens. 2006 Mar;15(2):130-4. doi: 10.1097/01.mnh.0000214771.88737.ee.